| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.699 | 36.237 | 41.040 | 50.335 | 61.926 | 62.948 | 64.629 | 77.788 | 96.630 | 118.758 |
| Total Income - EUR | 34.179 | 36.238 | 41.041 | 50.401 | 61.963 | 65.016 | 64.725 | 77.789 | 96.631 | 119.647 |
| Total Expenses - EUR | 23.240 | 15.976 | 17.414 | 17.908 | 29.916 | 27.438 | 37.136 | 44.920 | 52.766 | 55.039 |
| Gross Profit/Loss - EUR | 10.939 | 20.262 | 23.627 | 32.492 | 32.047 | 37.578 | 27.589 | 32.869 | 43.865 | 64.608 |
| Net Profit/Loss - EUR | 9.917 | 19.899 | 23.217 | 31.988 | 31.428 | 37.170 | 26.987 | 32.107 | 43.015 | 61.095 |
| Employees | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr Tăşedan Dana S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 59.556 | 57.511 | 114.070 | 98.830 | 83.000 | 67.459 |
| Current Assets | 11.021 | 21.351 | 24.182 | 33.097 | 33.474 | 44.817 | 24.267 | 7.479 | 36.242 | 44.058 |
| Inventories | 223 | 118 | 382 | 666 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.559 | 1.535 | 3.109 | 4.214 | 5.400 | 4.939 | 5.065 | 5.782 | 15.689 | 40.591 |
| Cash | 8.240 | 19.699 | 20.692 | 28.217 | 28.074 | 39.878 | 19.202 | 1.697 | 8.424 | 3.467 |
| Shareholders Funds | 9.973 | 19.955 | 23.271 | 32.042 | 62.849 | 98.828 | 90.269 | 59.389 | 102.223 | 61.145 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 1.048 | 1.396 | 911 | 1.055 | 30.181 | 3.500 | 48.068 | 46.920 | 17.019 | 50.372 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr Tăşedan Dana S.r.l.